Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.

We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says Bitcoin Created "Froth" In The Market. In ...

Eli Lilly stock has advanced more than 200% over ... revenue climb in the double digits in recent quarters and the stock price to take off. The shares have advanced more than 200% over the past ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... better. . " Cramer also commented on recent Bitcoin price action which saw the cryptocurrency dip below ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...

Eli Lilly is expanding the supply and cutting the ... Additionally, the company lowered the prices of the 2.5 mg and 5 mg vials to $349 and $499 per month, respectively. WEIGHTWATCHERS CEO SIMA ...